Literature DB >> 18450016

TAPPred prediction of TAP-binding peptides in antigens.

Manoj Bhasin1, Sneh Lata, G P S Raghava.   

Abstract

The transporter associated with antigen processing (TAP) plays a crucial role in the transport of the peptide fragments of the proteolysed antigenic or self-altered proteins to the endoplasmic reticulum where the association between these peptides and the major histocompatibility complex (MHC) class I molecules takes place. Therefore, prediction of TAP-binding peptides is highly helpful in identifying the MHC class I-restricted T-cell epitopes and hence in the subunit vaccine designing. In this chapter, we describe a support vector machine (SVM)-based method TAPPred that allows users to predict TAP-binding affinity of peptides over web. The server allows user to predict TAP binders using a simple SVM model or cascade SVM model. The server also allows user to customize the display/output. It is freely available for academicians and noncommercial organization at the address http://www.imtech.res.in/raghava/tappred.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18450016     DOI: 10.1007/978-1-60327-118-9_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Influence of high hydrostatic pressure on epitope mapping of tobacco mosaic virus coat protein.

Authors:  Daniel Ferreira de Lima Neto; Carlos Francisco Sampaio Bonafe; Clarice Weis Arns
Journal:  Viral Immunol       Date:  2014-03       Impact factor: 2.257

2.  Cross-modality deep learning-based prediction of TAP binding and naturally processed peptide.

Authors:  Hanan Besser; Yoram Louzoun
Journal:  Immunogenetics       Date:  2018-02-28       Impact factor: 2.846

3.  In silico approach for predicting toxicity of peptides and proteins.

Authors:  Sudheer Gupta; Pallavi Kapoor; Kumardeep Chaudhary; Ankur Gautam; Rahul Kumar; Gajendra P S Raghava
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

4.  Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b).

Authors:  Hilyatuz Zahroh; Ahmad Ma'rup; Usman Sumo Friend Tambunan; Arli Aditya Parikesit
Journal:  Drug Target Insights       Date:  2016-11-01

5.  Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential.

Authors:  Gandharva Nagpal; Salman Sadullah Usmani; Sandeep Kumar Dhanda; Harpreet Kaur; Sandeep Singh; Meenu Sharma; Gajendra P S Raghava
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

6.  In Silico Validation of D7 Salivary Protein-derived B- and T-cell Epitopes of Aedes aegypti as Potential Vaccine to Prevent Transmission of Flaviviruses and Togaviruses to Humans.

Authors:  Sathish Sankar; Mageshbabu Ramamurthy; Balaji Nandagopal; Gopalan Sridharan
Journal:  Bioinformation       Date:  2017-11-30

Review 7.  Best practices for bioinformatic characterization of neoantigens for clinical utility.

Authors:  Megan M Richters; Huiming Xia; Katie M Campbell; William E Gillanders; Obi L Griffith; Malachi Griffith
Journal:  Genome Med       Date:  2019-08-28       Impact factor: 11.117

8.  Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions.

Authors:  Usman Sumo Friend Tambunan; Feimmy Ruth Pratiwi Sipahutar; Arli Aditya Parikesit; Djati Kerami
Journal:  Bioinform Biol Insights       Date:  2016-04-28

Review 9.  Identifying neoantigens for use in immunotherapy.

Authors:  Sharon Hutchison; Antonia L Pritchard
Journal:  Mamm Genome       Date:  2018-08-24       Impact factor: 2.957

10.  The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.

Authors:  Manas Ranjan Dikhit; Sushmita Das; Vijaya Mahantesh; Akhilesh Kumar; Ashish Kumar Singh; Budheswar Dehury; Ajaya Kumar Rout; Vahab Ali; Ganesh Chandra Sahoo; Roshan Kamal Topno; Krishna Pandey; V N R Das; Sanjiva Bimal; Pradeep Das
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.